SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,865 | -53.9% | 14,780 | 0.0% | 0.00% | – |
| Q2 2023 | $19,214 | -37.9% | 14,780 | -15.9% | 0.00% | -100.0% |
| Q1 2023 | $30,941 | -43.9% | 17,580 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $55,201 | -35.8% | 17,580 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $86,000 | +17.8% | 17,580 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $73,000 | -36.0% | 17,580 | -10.2% | 0.00% | -50.0% |
| Q1 2022 | $114,000 | -22.4% | 19,580 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $147,000 | -33.5% | 19,580 | -20.3% | 0.00% | -33.3% |
| Q3 2021 | $221,000 | -28.5% | 24,580 | -4.8% | 0.00% | -25.0% |
| Q2 2021 | $309,000 | -5.5% | 25,820 | -1.0% | 0.00% | -20.0% |
| Q1 2021 | $327,000 | -20.0% | 26,090 | -0.6% | 0.01% | -28.6% |
| Q4 2020 | $409,000 | +15.5% | 26,240 | -29.9% | 0.01% | 0.0% |
| Q3 2020 | $354,000 | +2.3% | 37,440 | -3.1% | 0.01% | 0.0% |
| Q2 2020 | $346,000 | -58.2% | 38,640 | -70.2% | 0.01% | -66.7% |
| Q1 2020 | $827,000 | -26.7% | 129,755 | -3.8% | 0.02% | +23.5% |
| Q4 2019 | $1,129,000 | +70.8% | 134,935 | +84.9% | 0.02% | +88.9% |
| Q3 2019 | $661,000 | -56.7% | 72,990 | -48.5% | 0.01% | -55.0% |
| Q2 2019 | $1,527,000 | +13.4% | 141,737 | +0.4% | 0.02% | +11.1% |
| Q1 2019 | $1,346,000 | -1.5% | 141,137 | +18.6% | 0.02% | -10.0% |
| Q4 2018 | $1,367,000 | -88.7% | 119,037 | -83.3% | 0.02% | -86.8% |
| Q3 2018 | $12,055,000 | +149.0% | 711,237 | +108.6% | 0.15% | +149.2% |
| Q2 2018 | $4,841,000 | -17.9% | 340,940 | +9.9% | 0.06% | -18.7% |
| Q1 2018 | $5,895,000 | -46.0% | 310,240 | -53.4% | 0.08% | -39.5% |
| Q4 2017 | $10,921,000 | +124.2% | 665,890 | +105.0% | 0.12% | +121.4% |
| Q3 2017 | $4,872,000 | +56.0% | 324,815 | -8.5% | 0.06% | +51.4% |
| Q2 2017 | $3,124,000 | +53.7% | 355,015 | -9.2% | 0.04% | +48.0% |
| Q1 2017 | $2,033,000 | +169.3% | 390,915 | +57.8% | 0.02% | +150.0% |
| Q4 2016 | $755,000 | -21.4% | 247,665 | +19.4% | 0.01% | -16.7% |
| Q3 2016 | $960,000 | -71.3% | 207,365 | -64.2% | 0.01% | -42.9% |
| Q2 2016 | $3,350,000 | +84.9% | 578,680 | +93.2% | 0.02% | -12.5% |
| Q1 2016 | $1,812,000 | -34.6% | 299,515 | -1.3% | 0.02% | -36.8% |
| Q4 2015 | $2,772,000 | +61.2% | 303,565 | -0.5% | 0.04% | +65.2% |
| Q3 2015 | $1,720,000 | -66.4% | 305,000 | -33.9% | 0.02% | -61.7% |
| Q2 2015 | $5,119,000 | -26.6% | 461,620 | +3.8% | 0.06% | -26.8% |
| Q1 2015 | $6,971,000 | +521.3% | 444,600 | +502.4% | 0.08% | +583.3% |
| Q4 2014 | $1,122,000 | +113.3% | 73,800 | +51.2% | 0.01% | +100.0% |
| Q3 2014 | $526,000 | -40.4% | 48,800 | -15.6% | 0.01% | -33.3% |
| Q2 2014 | $883,000 | +4.1% | 57,800 | +23.2% | 0.01% | -18.2% |
| Q1 2014 | $848,000 | +103.4% | 46,900 | +56.3% | 0.01% | +83.3% |
| Q4 2013 | $417,000 | +32.4% | 30,000 | 0.0% | 0.01% | +50.0% |
| Q3 2013 | $315,000 | +101.9% | 30,000 | +50.0% | 0.00% | +100.0% |
| Q2 2013 | $156,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 1,539,994 | $11,550,000 | 0.74% |
| Golden State Equity Partners | 143,768 | $1,078,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 765,000 | $5,975,000 | 0.40% |
| WASATCH ADVISORS LP | 10,960,982 | $82,207,000 | 0.34% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $332,000 | 0.32% |
| EMC Capital Management | 61,394 | $460,000 | 0.25% |
| Rokos Capital Management LLP | 539,860 | $4,108,000 | 0.25% |
| Long Focus Capital Management, LLC | 245,000 | $1,838,000 | 0.24% |
| Vanguard Capital Wealth Advisors | 33,380 | $250,000 | 0.18% |
| Fort Sheridan Advisors LLC | 74,898 | $562,000 | 0.16% |